In this continuing education program, we will address the role of the pharmacist in the care of transgender patients. The activity addresses communication with patients on the use of correct pronouns, appropriate terminology, gender affirming care with pharmacological and non-pharmacological means, creating a welcoming pharmacy environment, and training of colleagues, staff, and outreach to the community to lend further support to transgender health issues.
This activity will provide an overview of the medications used in the treatment of HIV. Specifically, discussed will be the different classes of antiretrovirals, including the mechanism of action, common side effects, drug-drug interactions, and limitations or special considerations which are unique to specific agents.
In this continuing education program, we will identify legal barriers for transgender patients to access and obtain appropriate and necessary healthcare resources. Apply proper pronoun use, gain an understanding of legal name change and “dead naming” of a transgender patient.
In this continuing education program, we will discuss ways that healthcare providers can become more aware of barriers to COVID-19 vaccination uptake in underserved communities. Barriers range from physical and logistical barriers to myths and beliefs that result in vaccine hesitancy. Awareness of such issues will equip healthcare providers with the appropriate tools to accommodate for specific barriers in hopes to increase COVID-19 vaccination rates in underserved communities.
This program will provide an introduction address current treatment regimens, individual and community-level prevention and treatment of youth living with HIV/AIDS, and opportunities and barriers for inclusion of youth in HIV/AIDS clinical trials. Additionally, we will review Florida law as it pertains to HIV testing, including partner notification, privilege to warn, and testing in pregnant women.
In this continuing education program, we will recognizes and addresses differences and barriers in access to healthcare among transgender individuals such as Hispanic and Black/African-American transgender patients, HIV positive patients, elderly or adolescent transgender patients.